McKesson cements acquisition of Celesio
The US healthcare services and information technology company McKesson Corporation has cemented its acquisition of German pharmaceutical wholesale and retail company Celesio AG.
The company announced on 2 December 2014 that the Higher Regional Court in Stuttgart, Germany, had approved the registration of the profit and loss transfer agreement between the two organisations. The judicial approval means that the two companies are now legally entitled to work as an integrated company. This is the latest step in McKesson’s acquisition of Celesio, parent company of Lloydspharmacy, which has been ongoing for just over a year.
“With complementary geographic footprints, shared values, and industry expertise across multiple markets, we will now serve our customers as one of the largest pharmaceutical wholesalers and providers of logistics and healthcare services in the world,” says John H Hammergren, McKesson Corporation’s chairman and chief executive.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067313
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com